Tanshinones from Chinese Medicinal Herb Danshen (Salvia miltiorrhiza Bunge) Suppress Prostate Cancer Growth and Androgen Receptor Signaling

[1]  Wei Zhang,et al.  A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo , 2012, Investigational New Drugs.

[2]  S. Yeh,et al.  The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells , 2012, The Prostate.

[3]  G. Blackburn,et al.  Bioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in mice , 2011, International journal of cancer.

[4]  Soo-Jin Jeong,et al.  Galbanic Acid Isolated from Ferula assafoetida Exerts In Vivo Anti-tumor Activity in Association with Anti-angiogenesis and Anti-proliferation , 2011, Pharmaceutical Research.

[5]  I. Kang,et al.  Cryptotanshinone sensitizes DU145 prostate cancer cells to Fas(APO1/CD95)-mediated apoptosis through Bcl-2 and MAPK regulation. , 2010, Cancer letters.

[6]  Soo-Jin Jeong,et al.  Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway. , 2010, Biological & pharmaceutical bulletin.

[7]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[8]  B. Gary,et al.  A Novel Sulindac Derivative Lacking Cyclooxygenase-Inhibitory Activities Suppresses Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate Model , 2010, Cancer Prevention Research.

[9]  Ruiwen Zhang,et al.  FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer , 2010, Investigational New Drugs.

[10]  Ayako Nishimoto,et al.  Prolonged treatment with bicalutamide induces androgen receptor overexpression and androgen hypersensitivity , 2010, The Prostate.

[11]  Cheng Jiang,et al.  Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells. , 2010, Current cancer drug targets.

[12]  Jie Chen,et al.  Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer. , 2009, International journal of molecular medicine.

[13]  M. Dowsett,et al.  Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Xiaolei Zhang,et al.  Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro. , 2009, Oncology reports.

[15]  H. Scher,et al.  Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer , 2009, Science.

[16]  Hongbo Hu,et al.  Methyl-Selenium Compounds Inhibit Prostate Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate Model with Survival Benefit , 2009, Cancer Prevention Research.

[17]  Yong Zhang,et al.  Tanshinone IIA inhibits leukemia THP-1 cell growth by induction of apoptosis. , 2009, Oncology reports.

[18]  Jeremy J. W. Chen,et al.  Anticancer effects of tanshinone I in human non-small cell lung cancer , 2008, Molecular Cancer Therapeutics.

[19]  J. Brooks,et al.  A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells , 2007, Nucleic acids research.

[20]  Junming Guo,et al.  A novel class of pyranocoumarin anti–androgen receptor signaling compounds , 2007, Molecular Cancer Therapeutics.

[21]  Jie Zhang,et al.  Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells , 2007, Journal of Neuro-Oncology.

[22]  Zhong Zuo,et al.  Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use , 2005, Journal of clinical pharmacology.

[23]  H. Scher,et al.  Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Yuquan Wei,et al.  Potential anticancer activity of tanshinone IIA against human breast cancer , 2005, International journal of cancer.

[25]  D. Petrylak.  The current role of chemotherapy in metastatic hormone-refractory prostate cancer. , 2005, Urology.

[26]  辛燕,et al.  Effects of Cryptotanshinone and Tanshinone A on Proliferation, Lipid Synthesis and Expression of Androgen Receptor mRNA in Human Sebocytes in vitro , 2005 .

[27]  L. Nahar,et al.  Natural medicine: the genus Angelica. , 2004, Current medicinal chemistry.

[28]  Sung-Dae Cho,et al.  Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription. , 2004, Molecular cancer therapeutics.

[29]  C. Heinlein,et al.  Androgen receptor in prostate cancer. , 2004, Endocrine reviews.

[30]  G. Bubley,et al.  Bicalutamide Functions as an Androgen Receptor Antagonist by Assembly of a Transcriptionally Inactive Receptor* , 2002, The Journal of Biological Chemistry.

[31]  A. Ruffion,et al.  Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  S. Choi,et al.  Tanshinone IIA, an ingredient of Salvia miltiorrhiza BUNGE, induces apoptosis in human leukemia cell lines through the activation of caspase-3 , 1999, Experimental & Molecular Medicine.

[33]  Martin R. Schneider,et al.  Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system , 1999, British Journal of Cancer.

[34]  Y. G. Gao,et al.  [Sex hormone-like activity of Tanshinone (author's transl)]. , 1980, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

[35]  Wang Db,et al.  [Tanshinone in the treatment of acne (a primary report of 20 cases (author's transl)]. , 1980 .

[36]  Wei Zhang,et al.  Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells , 2012, International journal of cancer.

[37]  H. Kung,et al.  Oncogenic activation of androgen receptor. , 2009, Urologic oncology.

[38]  D. Han,et al.  Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells. , 2009, Cancer research.

[39]  C. Su,et al.  Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios. , 2008, International journal of molecular medicine.

[40]  Jae Heun Lee,et al.  Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells. , 2008, International journal of oncology.

[41]  J. Yeung,et al.  Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on HepG2 cells in relation to glutathione perturbation. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[42]  Junming Guo,et al.  Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer. , 2006, Cancer research.

[43]  Y. Xing.  Effects of Cryptotanshinone and Tanshinone Α on Proliferation, Lipid Synthesis and Expression of Androgen Receptor mRNA in Human Sebocytes in vitro , 2005 .

[44]  R. Vessella,et al.  Molecular determinants of resistance to antiandrogen therapy , 2004, Nature Medicine.

[45]  M. Mosaddik.  In vitro cytotoxicity of tanshinones isolated from Salvia miltiorrhiza Bunge against P388 lymphocytic leukemia cells. , 2003, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[46]  Hideo Araki,et al.  Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome. , 2003, Cancer research.

[47]  J. Trapman,et al.  The androgen receptor in prostate cancer. , 1996, Pathology, research and practice.

[48]  A. Liu,et al.  [Tanshinone in the treatment of acne (a primary report of 20 cases (author's transl)]. , 1980, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.